← Back to tracker
EO 14336
Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve
ActiveSigned August 13, 2025
Health and Life SciencesGovernmental – Public Policy and Government AffairsLife SciencesHealthcare
Summary
This EO directs HHS to identify approximately 26 critical drugs and ensure a six-month supply of their active pharmaceutical ingredients —preferably sourced domestically—is stockpiled in the Strategic Active Pharmaceutical Ingredients Reserve (SAPIR). Additionally, it requires an updated plan to maintain reserves for essential medicines, including opening a second SAPIR repository, to bolster supply chain resilience against future public health emergencies.
Timeline
Immediate; 30 days; 90 days; 120 days.
Deliverable
None.
Legal Challenges
No known legal challenges.